Immune checkpoint HLA-E:CD94-NKG2A mediates evasion of circulating tumor cells from NK cell surveillance-Reference-Cited by-同舟云学术

Immune checkpoint HLA-E:CD94-NKG2A mediates evasion of circulating tumor cells from NK cell surveillance

Published:2023-02 Issue:2 Volume:41 Page:272-287.e9
ISSN:1535-6108
Container-title:Cancer Cell
language:en
Short-container-title:Cancer Cell

Author:

Liu Xiaowei,Song Jinen,Zhang Hao,Liu Xinyu,Zuo Fengli,Zhao Yunuo,Zhao Yujie,Yin Xiaomeng,Guo Xinyu,Wu Xi,Zhang Hu,Xu Jie,Hu Jianping,Jing Jing,Ma Xuelei,Shi Hubing^ORCID

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference61 articles.

1. The future of immune checkpoint therapy;Sharma;Science (New York, N.Y.),2015

2. Fundamental mechanisms of immune checkpoint blockade therapy;Wei;Cancer Discov.,2018

3. Trial watch: the clinical trial landscape for PD1/PDL1 immune checkpoint inhibitors;Tang;Nat. Rev. Drug Discov.,2018

4. A paradigm shift in cancer immunotherapy: from enhancement to normalization;Sanmamed;Cell,2018

5. Cancer immunotherapy update: FDA-approved checkpoint inhibitors and companion diagnostics;Twomey;AAPS J.,2021

Cited by 56 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Ultrasensitive detection of circulating tumor cells in clinical blood samples by a three-dimensional network nanovehicle-based aptasensor platform;Sensors and Actuators B: Chemical;2024-04

2. Gut microbiota: A double-edged sword in immune checkpoint blockade immunotherapy against tumors;Cancer Letters;2024-02

3. Peripheral arterial rather than venous blood is a better source of circulating tumor cells in early lung cancer;Thoracic Cancer;2024-01-31

4. MHC-I upregulation safeguards neoplastic T cells in the skin against NK cell-mediated eradication in mycosis fungoides;Nature Communications;2024-01-25

5. Durable Attenuation of Tumor pH–Platelet Linkage Reinstates Bioorthogonal Targeting of Residual Tumors Post-Debulking;ACS Nano;2024-01-25